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Our earlier studies revealed that both MHC (Major
Histocomptibility Complex) and non-MHC genes are
associated with the susceptibility to pulmonary tuber-
culosis (TB).  To find out whether non-MHC genes
such as vitamin D receptor (VDR) and interleukin-1
receptor antagonist (IL-1RA) genes are associated
with the susceptibility to spinal TB (extrapulmonary
form of TB), the present study was carried out in spi-
nal TB patients (n=66) and spouses of TB patients
(spinal-TB and pulmonary-TB) ( n = 80) (family con-
tacts).  A trend towards an increased per cent genotype
frequency of IL-1RA genotype variant 22 (12.1%) was
seen in spinal TB patients when compared to the con-
trols (3.8%) (spouses of the patients) (P=0.057; odds
ratio 3.5).  No difference was observed in the frequency
of VDR genotypes between the overall spinal TB
patients and the family contacts.  However, the VDR
mutant genotype tt was seen at a higher frequency in
female patients with TB spine (TBS) (12.8%) than
female contacts (4.2%) ( P >0.05 not significant;
odds ratio 3.5). Among the contacts, a significantly
increased frequency of wild type genotype TT (wild
homozygotes) was seen in female contacts (55.1%)
than male contacts (16.1%) (P =0.0012).  Similarly
a significant decrease in tt genotype was seen in
female contacts (4.1%) than male contacts (25.8%)
(P=0.012). The present study suggests that IL-1RA
genotype 22 may be associated with the susceptibility
to spinal TB.  Moreover, vitamin D receptor tt geno-
type may be associated with the susceptibility to spinal
TB in female patients. The study reveals that multi-
candidate genes may be associated with the suscep-
tibility to spinal TB.
OUR studies showed that apart from Major Histocompati-
bility Complex1 (MHC), non-MHC genes such as func-
tional mutant homozygotes (FMH) of mannose binding
protein (MBP) (also known as mannose binding lectin,
MBL)2 and mutant variant genotype (tt) of vitamin D
receptor (VDR)3 are associated with the susceptibility to
pulmonary tuberculosis (TB). In the present study, attem-
pts have been made to find out whether VDR and inter-
leukin-1 receptor antagonist (IL-1RA) gene variants are
associated with the susceptibility to spinal TB. Vitamin
D3 (1,25 dihydroxy vitamin D3) is an immunoregulatory
hormone and activates monocytes and stimulates cell-
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mediated immunity4. Vitamin D plays a vital role on
monocyte/macrophage activation through vitamin D
receptor and it is known that Vitamin D is one of the few
mediators shown to impair the growth of M. tuberculosis
in the macrophages5. The effects of vitamin D are exerted
by the interaction with VDR. VDR is a nuclear hormone
and a member of the super family of steroid receptors
which has a wide role in the regulation of calcium
homeostasis in a variety of tissues6.
A cluster of a VDR alleles is linked to other genes in the
3' untranslated region (3’UTR) of VDR gene complex7,.8.
Biallelic polymorphisms have been shown in the VDR
gene. The 3' UTR allele polymorphisms are in strong
linkage disequilibrium with restriction fragment length
polymorphisms (RFLPs) located in intron 8 (BsmI and
ApaI) and exon 9 (TaqI) of the VDR region. The
polymorphisms identified in the gene cluster of VDR region
are (BsmI site, alleles B and b; ApaI site, alleles A and a;
TaqI site, alleles T and t; B, A and T are wild type alleles
and b, a and t, mutant alleles). Among the three polymor-
phisms, TaqI polymorphism has been shown to be func-
tionally more important.
The TaqI RELP defines a single base change C to T in
codon 352 at the 3' end of the VDR gene7. The less com-
mon allele of TaqI site designated as t (mutant allele) has
been associated with higher levels of mRNA expression8.
The tt genotype of the less common allele of TaqI site has
been shown to be associated with both mineral density8,
resistance to primary and secondary hyperparathyroid-
ism9, resistance to prostatic cancer10 and susceptibility to
various infectious diseases11.
In TB, monocytes/macrophages play a major role in the
host defence against M.tuberculosis and secrete inflam-
matory cytokines at the site of lesion12. IL-IRA is a cyto-
kine factor which competes for the IL-1 binding site.
IL-IRA is also known as an acute phase protein with
anti-inflammatory activities. The production of IL-1a and
IL-1b is antagonized by the IL-IRA genes/gene prod-
ucts13.  The genes for IL-1a, IL-1b, IL-1 receptor, IL-IRA
are located in chromosome 2.  IL-IRA gene sequence re-
vealed 86 base pair tandem repeat sequences (mini satel-
lite) in the intron 2 region14.  The IL-IRA allele 2 of the
repeat has been found to be associated with several auto-
immune diseases15-17. Macrophages from heterozygous
carriers of IL-IRA allele have been shown to produce
more IL-IRA and less IL- 1a than other genotypes18.
Numerous studies have revealed the association of
variant genotypes of VDR and IL-IRA genes in many
infectious and non-infectious diseases in various popula-
tions. Though VDR and IL-IRA genes play an immuno-
regulatory role in infectious diseases, including TB, little
attention had been paid to the VDR and IL-IRA gene
polymorphisms and their association with the susceptibil-
ity/resistance to pulmonary and extra pulmonary form of
TB. The goal of the present study was to find out whether
non-MHC genes such as VDR and IL-IRA gene variants* For Correspondence, (e-mail : trcicmr@vsnl.com)
are associated with the susceptibility to spinal TB
(extrapulmonary-TB).
Subjects included in this study were 66 spinal TB
patients and 80 family contacts (spouses of pulmonary TB
[n=47] and spinal tuberculosis [n=33] patients).  Among
the spinal TB patients, 27 were males and 39 were
females.  The mean age with standard error was 40.9+3.0
for males and 47.1+2.2 for females. Among the total
control subjects, 31 were males and 49 were females.  The
mean age with standard error was 55.3+3.5 for males
and 43.9+2.1 for females.
Patients with clinically and radiologically active form
of spinal TB involving any vertebral body from the first
thoracic to the first sacral, inclusive, were studied.  The
pre-treatment investigations were radiograph of the chest,
examination by culture of two specimens of pus from any
abscess or sinus, with radiographic evidence of pulmonary
TB.  All these patients had received a supervised short
course chemotherapy of 6 to 9 months duration and
followed up for a period of 5 years after treatment.  These
patients were treated 15 to 20 years earlier.  At the time of
blood sample collection, all these cured patients were in a
quiescent stage of the disease19.
Control subjects consisted of family contacts.  They
were living together with the patients before, during and
after treatment for a period of 10 to 15 years.  All the
family contacts were clinically normal at the time of
blood sample collection. The patients and the contacts
were not consanguineous to each other. The patients and
the contacts were randomly selected and belonged to the
same ethnic origin (Indo-Dravidian descent).  They were
Tamil-speaking south Indian population (belonging to
different communities/castes) living in and around
Chennai.
From the patients and control subjects, DNA was ext-
racted from peripheral blood white cells using salting out
procedure20.
Genotyping of VDR for spinal TB patients was carried
out by PCR-RFLP (polymerase chain reaction-restriction
fragment length polymorphism) method.  The TaqI site
gene polymorphisms at codon 352 of the VDR gene were
studied as described earlier10. Codon 352 in exon 9 is
polymorphic, existing as either ATC or ATT, both of
which code for isoleucine and the C >T change is associ-
ated with the loss of a TaqI restriction site. The resulting
alleles are designated t (TaqI site present) or T (TaqI site
absent) and three possible genotypes result: TT,  Tt and tt.
A 740 bp fragment of the VDR gene was amplified by
PCR using the primers 5'-CAG AGC ATG  GAC AGG
GAG CAA-3' and 5'-GCA ACT CCT CAT GGC TGA
GGT CTC-3' located within intron 8 and exon 9 of the
VDR gene8.
The PCR conditions were 94o c for 30s (denaturing),
63oC for 30 s (annealing) and 72oC for 1 min (extension)
(36 cycles) using 10nM TAPS [3-Tris (hydroxymethyl)
methyl aminopropane sulfonic acid], pH 8.8, 50 mM KCI,
1.5mM MgCI2, 0.01% gelatin (Bangalore Genei, India),
0.02 mM dNTPs, 0.01 mM of each primer, 100 ng of DNA
and 1 unit of Taq polymerase (Bangalore Genei, India) in
a 25 m1 reaction.
Ten microlitre of the PCR product was subjected to
TaqI restriction enzyme digestion at 650C for 3 h using
manufacturer’s buffer (Bangalore Genei, India).  The TaqI
enzyme digested product was electrohoretically (80 volts
for 1 h) run on a 2% agarose gel containing 0.2 ml of
ethidium bromide (10mg/ml).  Three banding patterns are
observed after digestion of the 740 bp amplification frag-
ment, depending upon genotype (a) wild homoaygous
(TT): absence of the TaqI polymorphism results in two
fragments of 495 bp and 245 bp, (b) mutant homozygous
(tt):  presence of the TaqI polymorphism results in
three fragments of 290 bp, 245 bp and 205 bp, and (c)
hetero-zygote carrier (Tt):  presence of all four fragments
495 bp, 290 bp, 245 bp and 205 bp.  The 245 bp fragment
is constant among all genotypes having been created by a
nonpolymorphic TaqI site within the amplification frag-
ment and acts as an internal control for digestion10.
Genotyping of IL_IRA was carried out as described
earlier3.21. The intron 2 of the IL-IRA gene contains a
minisatellite consisting of 2 to 6 copies of an 86 bp tandem
repeat sequence. IL-IRA gene was amplified using the
following primers:  5'-CTC AGC AAC ACT CCT AT-3',
and 5'-TCC TGG TCT GCA GGT AA-3'.
The PCR cycle condition was 94oC for 20 s, 58oC for
30s and 72oC for 30s (35 cycles), using 10 mM Tris-HCI,
pH 8.3, 25 mM KCI, 3 mM MgCI2, 0.2 mM dNTPs,
0.1 mM of each primer, 100 ng of DNA and 1 unit of Taq
polymerase (Bangalore Genei, India) in a 15 m1 reaction.
The size variants were typed by electrophoresis of the
PCR products in an ethidium-bromide stained 2% agarose
gel.  Based on the size (base pair) of the PCR products
different alleles were determined.  Further, based on the
frequencies of the alleles, they are termed as allele-1
(410 bp), 2 (240 bp), 3 (325 bp), 4 (500 bp) and 5
(595 bp).  Frequencies of the VDR and IL-IRA genotypes
in the spinal TB patients and controls were analysed using
c2 analysis with Yates correction by employing the Stat-
calc program (Epi Info, Version-5; USD; Stone Mountain,
GA).  The odds ratio (approximate relative risk) and the P-
values for significance have been represented wherever
necessary.
No difference was observed in the VDR genotype fre-
quencies of the overall spinal TB patients and contacts
(Table 1). However, a trend towards an increased fre-
quency of mutant homozygotes (tt) was seen in female
patients (12.8%) than female contacts (4.1%) (P>0.05
not significant; odds ratio 3.5).  Similarly, a trend towards
an increased frequency of wild type homozygotes (TT)
was seen in female contacts (55.1%) than female patients
(43.6%).  An opposite picture on the genotype frequencies
was seen in male patients and male contacts.  An increased
frequency of wild type homozygotes (TT) was observed  in
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male patients (37.0%) than male contacts (16.1%).  Simi-
larly, an increased frequency of mutant homozygotes (tt)
was seen in male contacts (25.8%) than male patients
(14.8%).  However, these increase were not significant.  A
significantly increased TT (wild type homoztgotes) geno-
type frequency was seen in female contacts (55.1%) than
male contacts (16.1%) (P=0.0012).  On the other hand, a
significantly increased mutant genotype (tt) was seen
in male contacts (25.8%) than female contacts (4.1%)
(P=0.012).  However, such difference were not observed
between male patients and female patients.
No difference was observed in the frequency of the
variant IL-1RA genotypes between patients and control
subjects (Table 2).  However, a trend towards an increased
percentage frequency of the variant IL-1RA genotype 22
was seen in spinal TB patients (12.1%) than patient con-
tacts (3.8%). (P=0.057; odds ratio 3.5).
In the present study, VDR gene variants are not associ-
ated with the susceptibility to spinal TB in the overall
patient group. However, a trend towards an increased fre-
quency of VDR mutant genotype (tt) was seen in female
patients with spinal TB compared to female contacts.  Our
earlier study in pulmonary TB revealed an increased VDR
mutant genotype (tt) in female patients with pulmonary-
TB3. Moreover, the wild type homozygotes (TT) are
found to be decreased in female patients than female con-
tacts. This suggests that the mutant genotype (tt) of VDR
may be associated with the susceptibility to both pulmo-
nary and spinal TB in female patients.  On the contrary, a
trend towards an increased frequency of VDR wild type
genotype (TT) was seen with male spinal TB patients than
male contacts.  Moreover, a decreased frequency of mutant
genotype tt was seen with male patients than male con-
tacts.  This suggests that wild type genotype TT may be
associated with the susceptibility to spinal TB in male
patients and the mutant genotype tt may be associated
with resistance in male patients.  However, to sustantiate
this preliminary study further work is needed.  The present
study suggests that mutant homozygotes (tt) of the VDR
gene may contribute  to host genetic variation in the out-
come of TB in female subjects and resistance in male sub-
jects.  Allelic variants of the VDR appear to be associated
with differential susceptibility to several infectious and
non-infectious diseseas11.  In the Gambian pulmonary TB
patients, the tt genotype (mutant homozygotes) was found
less frequently in cases of pulmonary TB suggesting that
this genotype is associated with resistance to pulmonary
TB22.  Further, in a study carried out in Indian leprosy
patients, Ray et al.23 have found tt genotype to be associ-
ated with tuberculoid leprosy, whereas the opposite TT
genotype was associated with lepromatous leprosy.
Our earlier study in pulmonary TB3 and the present
study in spinal TB suggest that tt genotype may be associ-
ated with the susceptibility to pulmonary TB as well as
extrapulmonary forms of TB in females.  Mutant alleles of
the VDR gene region have been shown to be associated
with increased (TaqI site: mutant allele t) and decreased
(BsmI site: mutant allele b) transcriptional activity of the
VDR region8. It has been shown that allele t plays an imp-
ortant role in female subjects.  The VDR genotype tt is
associated with bone mineral density as well as suscepti-
bility to TB in females24.25. The females sex hormones as
well as calcium intake probably influence the expression
of the VDRs.  This may influence the vitamin D-mediated
monocyte/macrophage activation through VDRs. This in
turn may influence the cidal activity of the monocyte/
macrophage function against M.tuberculosis. It has
been suggested that VDR gene polymorphism may be of
immunoregulatory importance for many disease pro-
cesses22.23. However, the immune mechanism of suscepti-
bility to pulmonary or extrapul-monary TB as far as TaqI
polymorphism of VDR gene is concerned, has to be fur-
ther explored with the other genes of the VDR region.
In the present study, increased genotype frequency of
IL-IRA 22 was seen in the patients compared to control
subjects.  The less common allele 2 (containing just two
repeats of 86 bp) has been shown to be associated with
increased IL-IRA protein production as well as decreased
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Contacts             Spinal - TB patients
 (n=80)    (n=66)
1 1 48.7 50.0
1 2 41.3 31.8
14 6.3 4.6
22. 3.8* 12.1*
24 0.0 1.5
* X2 P (uncorrected) 0.057: Odds ratio : 3.5
IL-1 RA
genotype
variants
 % Genotype frequency
Table 2.  Pre cent genotype frequencies of IL-1RA alleles
in spinal TB patients and contacts
Overall contacts      Overall patients      Female contacts      Female patients     Male contacts     Male patients
       (n =80) (n =66) (n =49) (n =39)               (n =31)               (n =27)
TT (Wild homozygotes) 40.0 40.9  55.1*    43.6                      16.1* 37.0
Tt (Heterozygote carrier) 47.5 45.5  40.8    43.6                      58.1 48.2
tt (Mutant homozygotes) 12.5 13.6  4.1**@    12.8@                    25.8** 14.8
T, wild type allele : t, mutant allele.
@
 c2 P uncorrected > 0.05 (not significant : Odds ratio : 3.5): * c2 P (corrected) = 0.0012; ** c2 P (corrected) = 0.012
VDR genotype variants
Table 1. Per cent genotype frequencies of VDR genes in female and male patients with spinal TB and contacts.
% Genotype frequency
IL-1a production18.  It has been suggested that the poly-
morphism in the IL-IRA gene may be present in the
regulatory area itself or in linkage disequilibrium with
another polymorphism that regulates the transcription of
both IL-IRA and Il-1a genes18. The variable repeat
sequence has been shown to contain three potential pro-
tein binding sites: an IFN-a silencer A, an IFN-b silencer
B, and an acute phase response element21.  Further, it has
been suggested that the variable tandem repeat polymor-
phism in intron 2 of the human IL-IRA gene may affect
the activity of enhancer sequences that affect the trans-
cription of the IL-1RA gene and other cytokine genes18.
Several autoimmune diseases have been shown to be
associated with IL-IRA allele 2 (refs 15-17).  Our earlier
study did not show any association with IL-IRA allele 2
and pulmonary TB3.  However, increased frequency of IL-
IRA genotype 22 was seen in spinal TB patients.  IL-IRA
allele 2 has been shown to be associated with increased
production of IL-IRA protein (anti-inflammatory) and
decreased IL-1a produc-tion (one of the inflammatory
cytokines).  The association on IL-IRA genotype 22 with
spinal TB found in the present study may be due to
increased production of IL-IRA protein study may be due
to increased production of IL-IRA protein at the site of
lesion in the spinal column to antagonize the inflamma-
tory action of IL-1a as wells as the IL-1b cytokites.  This
in turn gives protection against the detrimental effects of
the inflammatory cytokines such as IL-1a and IL-1b at
the site of lesion.
The present study suggests that VDR and IL-IRA geno-
types may be associated with the susceptibility to spinal
TB. Moreover, these genes may also play an immunoregu-
latory role in the mechanism of susceptibility/resistance to
pulmonary as well as extrapulmonary forms of TB.
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